BIOVERIC Pharmaceuticals, Inc. – Developing New Drug Products For Patients With Unmet Needs

About Us

We are developing new drug products with dosage form innovation for patients with unmet needs. Our pipeline includes drug product candidates with promising market and potential intellectual property. We are focused to design and develop innovative drug products to revolutionize drug delivery for better patient outcome. We use 505(b)(2) regulatory pathway, enabling quicker and more cost-effective approvals by utilizing FDA’s finding for safety and efficacy of the drugs.

Our mission is to create a world where every patient is treated conveniently with safe and effective medicines. Our vision is to specialize in patient-centric innovative drug delivery.

Reduce Side Effects
Our dosage form innovations are intended to eliminate or reduce side-effects of existing products.

Avoid Dosing Error
We develop ready-to-use dosage forms that do not require preparation by end user or pharmacist.

Improved Product Stability
Our difficult to formulate dosage forms have improved stability for cost-effective storage and handling.

Boost Patient Compliance
Our dosage form innovations are intended to boost patient compliance in population with special needs.

Leadership

BIOVERIC Pharmaceuticals’ leadership team brings decades of expertise in drug product development, scale-up, technology transfer, and commercial manufacturing. Our leaders have successfully managed projects across diverse settings, from small startups to large multinational corporations, ensuring excellence throughout the pharmaceutical lifecycle. We specialize in creating innovative formulations and scaling them efficiently from concept to full production. With a strong track record in seamless technology transfers, we maintain high-quality standards and adaptability across all manufacturing sites. Our commitment to operational excellence and patient-centered solutions drives our impact on global healthcare.